Bellevue Group Ag has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $4.39 Billion distributed in 175 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $315M, Ionis Pharmaceuticals Inc with a value of $310M, Neurocrine Biosciences Inc with a value of $229M, Alnylam Pharmaceuticals, Inc. with a value of $221M, and Abbott Laboratories with a value of $213M.
Examining the 13F form we can see an increase of $85.2M in the current position value, from $4.31B to 4.39B.
Bellevue Group Ag is based out at Kuesnacht, V8
Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.
Portfolio value
$4.39 Billion
Healthcare: $4.39 Billion
ETFs: $3.77 Million
Technology: $608,000
Consumer Cyclical: $546,000
Communication Services: $426,000
Consumer Defensive: $202,000
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
